EpiDisease — Grant · approximately €1.9M

EpiDisease received about €1.9M in non-dilutive funding from CDTI and the EU, through the Horizon Europe SME Seal of Excellence scheme and NextGenerationEU funds. The money goes to its IVD HISTSHOCK test for diagnosing and predicting sepsis and septic shock: a multicentre international clinical trial in Spain, Italy, Denmark and the Netherlands, and the technical file for EU regulators. The record on file (id 4465) has the date 2026-10-24, but El Referente reported this grant on 11 May 2023 and the PCUV newsroom on 19 May 2023. The date should be corrected to 2023-05-11. Separately, a July 2018 Novobrief/EFE Emprende report said Fundación Botín's Mind the Gap programme 'will invest' €344K over two years. No source confirms that money was paid, so it is not reported as a round. Dealroom lists no known external funding.